Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion type Assertion NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_head.
- NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion description "[Six genes were identified as of interest for a follow-up, based on the strength of the association and based on the interest as potential candidate target for developing new treatment for depression: Solute Carrier Family 4 Member 10 (SLC4A10), Dipeptidyl Peptidase IV (DPP4), Dopamine Receptor D3 (DRD3), Zinc Finger Protein 80 (ZNF80), Nitric Oxide Synthase 2A (NOS2A) and Peroxisome Proliferator-Activated Receptor-Gamma, Coactivator 1, Alpha (PPARGC1A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_provenance.
- NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion evidence source_evidence_literature NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_provenance.
- NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion SIO_000772 21630437 NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_provenance.
- NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion wasDerivedFrom befree-2016 NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_provenance.
- NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_assertion wasGeneratedBy ECO_0000203 NP898502.RAZIiy-KI9-acRUetmJNiw3ZZn4ojmEoFmxfpdSuc4Hak130_provenance.